Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Myocardial Infarction: later-stage trial registry
16 of 66 indexed Myocardial Infarction trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #211 of 28,707 conditions by registered trial count.
66 US clinical trials · 16 currently recruiting · #211 of 28,707 conditions by registered trial count
Myocardial Infarction: 66 US clinical trials tracked, 16 recruiting.
Myocardial Infarction is the subject of 66 registered US clinical trials on ClinicalTrials.gov, 16 of them currently open to new participants. 14 are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most active sponsor is NYU Langone Health, running 5 of these trials.
Enrollment posture brief
Registry condition myocardial-infarction
OPEN 16 | RECR 24% | LATE 14 | EARLY 7 | RANK #211 | SPON 5
Volume-matched condition peers
Nearest open-share peer: Anatomic Stage IIB Breast Cancer AJCC v8 (24% recruiting · 33 trials)
Myocardial Infarction lists 16 open slots (24% of 66 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Myocardial Infarction on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Myocardial Infarction is recruiting below its size-band peers.
16 of 66 indexed trials (24.2%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Myocardial Infarction trials is spread across many organizations.
NYU Langone Health accounts for 5 of 66 trials (7.6%). 47 distinct sponsors appear on at least one study for this condition label.
-
Typical Myocardial Infarction enrolment sits around 360 participants.
Median target enrolment is 360 among the 65 trials that report a genuine target (sentinel values excluded). 12 of those (18.5%) plan for fewer than 100 participants.
-
Myocardial Infarction splits between interventional and observational designs.
38 interventional and 28 observational studies make up this index (57.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
66 total, page 1 of 2
Vascular Events In Patients Undergoing Same-day Noncardiac Surgery (VALIANCE) Study
Centre hospitalier de l'Université de Montréal (CHUM)
NCT04973397
Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
Brigham and Women's Hospital
NCT01258231
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
Peerbridge Health
NCT06699056
Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II
AliveCor
NCT06271577
Circulating Markers for Ischemic Heart Disease
UConn Health
NCT00762333
Reducing Blood Pressure in Patients With High Cardiovascular Risk
University of Southern California
NCT05937685
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
University of California, San Francisco
NCT05933083
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
ROM Technologies
NCT05972070
Heart Attack Research Program: Platelet Sub-Study (HARP)
NYU Langone Health
NCT03022552
Improving Cardiac Rehabilitation Exercise Using Target Heart Rate Trial
Baystate Medical Center
NCT05925634
Study of Circulating Monocytes in Patients With Ischemic Vascular Disease
UConn Health
NCT04321512
Women's Heart Attack Research Program: Stress Ancillary Study
NYU Langone Health
NCT02914483
Diffusion MRI in Heart Failure
Massachusetts General Hospital
NCT02973633
Influence of Pulse Electromagnetic Field Therapy on Myocardial Ischemia
Mayo Clinic
NCT05111288
Examination of the Impact of CalmiGo's Stress Management Device on Vascular Heath and Cardiovascular Disease Risk.
Mayo Clinic
NCT04521699
Cardiac Radioablation for VT
Corewell Health East
NCT06593418
Genomic Investigation of Cardiovascular Diseases
Scripps Translational Science Institute
NCT00722748
EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction
Amgen
NCT05284747
Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes Registry
Chiesi USA
NCT04076813
Ventricular Remodeling and Heart Failure After Myocardial Infarction: A Community Study
Mayo Clinic
NCT02047396
Heart Attack Research Program- Imaging Study
NYU Langone Health
NCT02905357
Acute Kidney Injury Genomics and Biomarkers in TAVR Study
University of Texas Southwestern Medical Center
NCT02791880
Research on Infarction With Open Arteries Using OCT and CMR
NYU Langone Health
NCT02270359
Neuroinflammation After Myocardial Infarction - Imaging Substudy
University of Alabama at Birmingham
NCT03968445
Type 2 Diabetes With Antiplatelet Drugs
Tabula Rasa HealthCare
NCT05053828
An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
NCT00809965
Testing a Community Intervention to Increase Aspirin Use
University of Minnesota
NCT02607917
SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary Syndromes
Sanofi
NCT00043784
The PACE-MI Registry Study - Outcomes of Beta-blocker Therapy After Myocardial Infarction (OBTAIN)
Northwestern University
NCT00430612
Home Use of Automatic External Defibrillators to Treat Sudden Cardiac Arrest
National Heart, Lung, and Blood Institute (NHLBI)
NCT00047411
ECG Methods for the Prompt Identification of Coronary Events
University of Pittsburgh
NCT04237688
INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
Brigham and Women's Hospital
NCT02787044
Occluded Artery Trial (OAT)
NYU Langone Health
NCT00004562
An Observational Study of Cholesterol in Coronary Arteries
Infraredx
NCT00831116
Safety of Nitroglycerin for Field Treatment of STEMI
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
NCT02407002
IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium.
Tufts Medical Center
NCT00091507
Heart Rate Variability and Sudden Cardiac Death
Columbia University
NCT00005235
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
University of Calgary
NCT00673842
A Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Myocardial Infarction Patients
Intermountain Health Care
NCT02996721
Disrupt CAD III With the Shockwave Coronary IVL System
Shockwave Medical
NCT03595176
MCC-135 as Adjunct Therapy to Primary Percutaneous Coronary Intervention in ST-Segment Elevation Acute Myocardial Infarction Patients
Tanabe Pharma Corporation
NCT00078013
Pre-hospital Administration of Thrombolytic Therapy With Urgent Culprit Artery Revascularization
The University of Texas Health Science Center, Houston
NCT00178620
Rule Out Myocardial Infarction by Computer Assisted Tomography
Massachusetts General Hospital
NCT00990262
MRI Evaluation of Chest Pain
National Heart, Lung, and Blood Institute (NHLBI)
NCT00001961
Effect of High Dose Fish Oil Supplementation After Recent Heart Attack Using Magnetic Resonance Imaging
Brigham and Women's Hospital
NCT00729430
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
University of Washington
NCT00880178
At-Home Automated External Defibrillator (AED) Training Study
Public Health - Seattle and King County
NCT00219674
Diagnostic Utility of Contrast Echocardiography for Detection of LV Thrombi Post ST Elevation Myocardial Infarction
Weill Medical College of Cornell University
NCT00539045
Bupropion for Hospitalized Smokers With Acute Cardiovascular Disease
Massachusetts General Hospital
NCT00181818
The Relationship Between the Response to Mental Stress and Vascular Endothelial Function
Mayo Clinic
NCT00975559
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 4 |
| Phase 3 | 9 |
| Phase 4 | 5 |
Top Sponsors
Named interventions
Most-linked intervention names on Myocardial Infarction records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Myocardial Infarction trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Myocardial Infarction page
66 registered trials, 16 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 16 Myocardial Infarction trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- NYU Langone Health sponsors the most Myocardial Infarction trials on record, review their full trial history before evaluating a specific study. See NYU Langone Health's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Myocardial Infarction condition card totals 66 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.